Background: The DynaPort Activity Monitor (DAM) has been reported to be useful to evaluate the activity in healthy subjects and patients with chronic obstructive pulmonary disease (COPD). However, it is difficult to estimate the activity of COPD patients using DAM, because its battery works only for several hours and sensors should be worn at two parts of the body. A newly developed compact, single-position triaxial accelerometer (Actimarker) can measure the activity for >1 month, but has not been validated for COPD patients. Objectives: The validity of the Actimarker was evaluated in COPD patients. Methods: In study 1, the validity of the device was tested in 14 stable COPD patients by comparing it with DAM. In study 2, the influence of the weather on activity was examined. In study 3, the number of measurement days required to ensure repeatability was determined. Results: The durations of activity measured by the Actimarker and DAM were significantly correlated at intensity values ≧2.0, ≧2.5 and ≧3.0 METs. The duration of activity on rainy days was significantly shorter than that on non-rainy days. The values of intraclass correlation coefficients were >0.8 in 3-, 4- or 5-day measurements, and there was no systematic bias at any number of days or intensities with Bland-Altman plots. Conclusions: The validity of the Actimarker was confirmed, and repeatability was obtained when the data from at least 3 non-rainy weekdays were analyzed. Actimarker appears to be useful as a simplified method to evaluate the physical activity of COPD patients.

1.
Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM: Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007;175:458–463.
2.
Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R: Physical activity and hospitalization for exacerbation of COPD. Chest 2006;129:536–544.
3.
Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM: Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003;58:100–105.
4.
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE: Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002;346:793–801.
5.
Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM: Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006;61:772–778.
6.
Schonhofer B, Ardes P, Geibel M, Kohler D, Jones PW: Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. Eur Respir J 1997;10:2814–2819.
7.
Steele BG, Holt L, Belza B, Ferris S, Lakshminaryan S, Buchner DM: Quantitating physical activity in COPD using a triaxial accelerometer. Chest 2000;117:1359–1367.
8.
Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H: Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008;177:743–751.
9.
Pitta F, Takaki MY, Oliveira NH, Sant’anna TJ, Fontana AD, Kovelis D, Camillo CA, Probst VS, Brunetto AF: Relationship between pulmonary function and physical activity in daily life in patients with COPD. Respir Med 2008;102:1203–1207.
10.
Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R: Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J 2006;27:1040–1055.
11.
Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, Perez-Izquierdo J, Aizpiri S, Aguirre U, Capelastegui A: Impact of changes in physical activity on health-related quality of life among patients with COPD. Eur Respir J 2010;36:292–300.
12.
Benzo RP, Chang CC, Farrell MH, Kaplan R, Ries A, Martinez FJ, Wise R, Make B, Sciurba F: Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease. Respiration 2010;80:10–18.
13.
Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R: Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2005;86:1979–1985.
14.
Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R: Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972–977.
15.
Pitta F, Troosters T, Probst VS, Lucas S, Decramer M, Gosselink R: Potential consequences for stable chronic obstructive pulmonary disease patients who do not get the recommended minimum daily amount of physical activity. J Bras Pneumol 2006;32:301–308.
16.
Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, Lopez-Collazo E, Alvarez-Sala R: Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009;180:506–512.
17.
Watz H, Waschki B, Meyer T, Magnussen H: Physical activity in patients with COPD. Eur Respir J 2009;33:262–272.
18.
Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2009. www.goldcopd.com (accessed December 2010).
19.
Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i:307–310.
20.
Bland JM, Altman DG: Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995;346:1085–1087.
21.
Baranowski T, de Moor C: How many days was that? Intra-individual variability and physical activity assessment. Res Q Exerc Sport 2000;71:S74–S78.
22.
Matthews CE, Ainsworth BE, Thompson RW, Bassett DR Jr: Sources of variance in daily physical activity levels as measured by an accelerometer. Med Sci Sports Exerc 2002;34:1376–1381.
23.
Tudor-Locke C, Burkett L, Reis JP, Ainsworth BE, Macera CA, Wilson DK: How many days of pedometer monitoring predict weekly physical activity in adults? Prev Med 2005;40:293–298.
24.
Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD: Can individualized rehabilitation improve functional independence in elderly patients with COPD? Chest 2005;128:1194–1200.
25.
Hill K, Dolmage TE, Woon L, Goldstein R, Brooks D: Measurement properties of the SenseWear armband in adults with chronic obstructive pulmonary disease. Thorax 2010;65:486–491.
26.
Langer D, Gosselink R, Sena R, Burtin C, Decramer M, Troosters T: Validation of two activity monitors in patients with COPD. Thorax 2009;64:641–642.
27.
Crouter SE, Clowers KG, Bassett DR Jr: A novel method for using accelerometer data to predict energy expenditure. J Appl Physiol 2006;100:1324–1331.
28.
Welk GJ, McClain JJ, Eisenmann JC, Wickel EE: Field validation of the MTI Actigraph and BodyMedia armband monitor using the IDEEA monitor. Obesity (Silver Spring) 2007;15:918–928.
29.
Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Heath GW, King AC, et al: Physical activity and public health. A recommendation from the centers for disease control and prevention and the American College of Sports Medicine. JAMA 1995;273:402–407.
30.
Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O’Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO, Jacobs DR Jr, Leon AS: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498–S504.
31.
Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, Macera CA, Castaneda-Sceppa C: Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007;39:1435–1445.
32.
Lopez Varela MV, Montes de Oca M, Halbert RJ, Muino A, Perez-Padilla R, Talamo C, Jardim JR, Valdivia G, Pertuze J, Moreno D, Menezes AM: Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 2010;36:1034–1041.
33.
Torres SH, Montes de Oca M, Loeb E, Mata A, Hernandez N: Gender and skeletal muscle characteristics in subjects with chronic obstructive pulmonary disease. Respir Med 2011;105:88–94.
34.
van Weel C, Schellevis FG: Comorbidity and guidelines: conflicting interests. Lancet 2006;367:550–551.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.